Article ID Journal Published Year Pages File Type
8283952 Maturitas 2018 7 Pages PDF
Abstract
This proof-of-principle study demonstrates that reverse engineering of TNBC cells might offer a novel targeted treatment strategy for this most aggressive subtype of breast cancer.
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Ageing
Authors
, , , , ,